ArticlemAbs

Simlukafusp alfa (FAP-IL2v) immunocytokine is a versatile combination partner for cancer immunotherapy.

Inja Waldhauer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.